Skip to content

艾米克斯生物制药

US · IMMX #3426 按市值排名 上市于 2021
7.98 -0.70 -8.06%
实时 - 追踪5344个代码 - 心跳于284秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期(2026/Q3)披露持股的机构数量增加了2家。
  • 机构持股总比例下降了12.0个百分点。

机构持股

机构持股比例
74.77% -11.95pp
机构数量
136 +2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund42.39%
Hedge Fund17.60%
VC/PE Fund8.53%
Individual/Insider8.20%
Private Company5.22%
Public Company0.84%
Insurance Company0.11%
Other17.04%

主要股东 截至 2026-06-30

Janus Henderson Group plc 11.80% · 9.78M 股
Saturn V Capital Management LP 5.62% · 4.66M 股
Veritas Liberabit Vos, LLC 4.72% · 3.92M 股
Eventide Asset Management, LLC 4.69% · 3.89M 股
Yekaterina Chudnovsky 3.91% · 3.24M 股
State Street Global Advisors 3.61% · 3.00M 股
BlackRock 3.61% · 2.99M 股
Vanguard Capital Management, LLC 3.51% · 2.91M 股
Deep Track Capital, LP 3.35% · 2.78M 股
Opaleye Management Inc. 2.83% · 2.35M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 47次买入 · 0次卖出

姓名职务持股比例
Yekaterina Chudnovsky Director 3.91%
Ilya Rachman Chairperson & CEO 1.38%
Jason Hsu Director 1.14%
Patricia Gallup -- 0.60%
Nancy Chang Director 0.51%
Gabriel Morris Chief Financial Officer 0.35%
Helen Adams Independent Director 0.21%
Magda Marquet Independent Director 0.06%
Jane Buchan Independent Director 0.03%
Carey Ng Independent Director 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-05-21 Nancy Chang Director Other Acquisition +6,250 --
2026-05-21 Nancy Chang Director Other Derivative Acquisition +12,500 $8.78
2026-05-21 Jane Buchan Independent Director Other Acquisition +6,250 --
2026-05-21 Jane Buchan Independent Director Other Derivative Acquisition +12,500 $8.78
2026-05-21 Jason Hsu Director Other Acquisition +6,250 --
2026-05-21 Jason Hsu Director Other Derivative Acquisition +12,500 $8.78
2026-05-21 Magda Marquet Independent Director Other Acquisition +6,250 --
2026-05-21 Magda Marquet Independent Director Other Derivative Acquisition +12,500 $8.78
2026-05-21 Helen Adams Independent Director Other Acquisition +6,250 --
2026-05-21 Helen Adams Independent Director Other Derivative Acquisition +12,500 $8.78
2026-05-21 Carey Ng Independent Director Other Acquisition +6,250 --
2026-05-21 Carey Ng Independent Director Other Derivative Acquisition +12,500 $8.78
2026-05-21 Ilya Rachman Chairperson & CEO Other Derivative Acquisition +500,000 $8.78
2026-05-21 Gabriel Morris Chief Financial Officer Other Derivative Acquisition +500,000 $8.78
2026-05-21 Yekaterina Chudnovsky Director Other Acquisition +6,250 --
2026-05-21 Yekaterina Chudnovsky Director Other Derivative Acquisition +12,500 $8.78
2025-12-09 Ilya Rachman Chairperson & CEO Open Market Acquisition +746 $6.67
2025-12-09 Gabriel Morris Chief Financial Officer Open Market Acquisition +770 $6.58
2025-12-07 Alwaysraise LLC -- Derivative Exercise and Retained +156,000 $0.80
2025-11-20 Nancy Chang Director Other Derivative Acquisition +39,643 $4.33

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

艾米克斯生物制药 讨论区 0 条评论

发表评论